Fiducial Markers Market to Grow with a CAGR of 5.25% through 2029
Rising incidence of cancer and growing awareness among
healthcare professionals are factors driving the Global Fiducial Markers Market in the forecast
period 2025-2029
According to TechSci
Research report, “Fiducial Markers Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2029”, the Global Fiducial
Markers Market stood at USD 92.52 Million in 2023 and is anticipated to grow
with a CAGR of 5.25% in the forecast period, 2025-2029. Fiducial
markers play a crucial role in various medical imaging and radiotherapy
procedures, providing reference points for accurate targeting and treatment.
The global fiducial markers market has witnessed substantial growth in recent
years, driven by a combination of technological advancements, increasing
prevalence of cancer, and a growing demand for precise and targeted medical
interventions. Cancer remains a
major global health challenge, with a continuous increase in incidence rates.
Fiducial markers are extensively used in the field of oncology for radiotherapy
and image-guided interventions. As the prevalence of cancer rises, the demand
for fiducial markers to enhance the accuracy and effectiveness of cancer
treatments also grows.
Browse
over XX market data Figures spread through XX Pages and an in-depth TOC on
"Global Fiducial Markers Market”
The growth of the fiducial markers market has been propelled by advancements in medical imaging technologies. Sophisticated modalities like CT, MRI, and ultrasound allow for improved tumor visualization and precise marker placement. Integrating fiducial markers with these technologies is crucial for enhancing diagnostic and treatment precision, particularly in personalized and targeted therapies. Healthcare professionals increasingly recognize the benefits of fiducial markers, leading to a surge in demand.
Moreover, rising awareness among practitioners about the advantages of fiducial markers in improving treatment outcomes further drives market growth. Beyond oncology, fiducial markers find applications in neurology, cardiology, and other specialties, expanding the market's scope and sustaining its growth trajectory.
The Global Fiducial
Markers Market is segmented into product,
modality, cancer type, end user and company
Based
on cancer type, the Prostate
Cancer segment has emerged as the predominant market leader. The use of
fiducial markers in prostate cancer treatment has not only improved treatment
accuracy but also contributed to better patient outcomes and enhanced quality
of life. By minimizing damage to surrounding healthy tissues, patients
experience fewer side effects, leading to a more positive post-treatment
experience. Additionally, the targeted nature of fiducial marker-guided
radiation therapy often allows for shorter treatment durations, reducing the
overall impact on patients' daily lives.
Based on region,
North America segment is expected to grow during the forecast period. North American companies have been proactive in
forming collaborations and partnerships with healthcare institutions, research
centers, and other stakeholders. These collaborations facilitate the
development and distribution of fiducial markers, giving North American
companies a competitive edge in the global market.
The Asia Pacific
region is experiencing rapid market growth. The region's commitment to
healthcare is evident in substantial investments in research and development.
The continuous influx of funds into the healthcare sector has propelled the
development of innovative medical technologies, including fiducial markers.
Major companies
operating in Global Fiducial Markers Market are:
·
CIVCO Radiotherapy
·
IZI Medical Products
·
Boston Scientific Corporation
·
Naslund Medical AB
·
Best Medical International, Inc.
·
Nanovi A/S
·
Carbon Medical Technologies Inc.
·
Eckert & Ziegler
·
Innovative Oncology Solutions
·
Medtronic plc
Download Free Sample Report
Customers can
also request 10% free customization on this report
“The
global fiducial markers market is poised for sustained growth, driven by a
convergence of factors ranging from the rising incidence of cancer to
technological advancements and collaborative efforts within the healthcare
industry. As the demand for precision in medical interventions continues to
increase, fiducial markers will remain a critical component in enhancing the
accuracy and effectiveness of various diagnostic and therapeutic procedures
across multiple medical specialties.” said Mr. Karan Chechi, Research Director
with TechSci Research, a research-based management consulting firm.
“Fiducial Markers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Metal-based Markers, Polymer-based Markers, Other Fiducial Markers), By Modality (CT/CBCT, MRI, Ultrasound, Radiotherapy), By Cancer Type (Prostate Cancer, Lung Cancer, Breast Cancer, Gastric Cancer, Other Cancers), By End User (Hospitals & Clinics, Independent Radiotherapy Centers, Cancer Research Centers), By Region and Competition, 2019-2029F”,
has evaluated the future growth potential of Global Fiducial Markers Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Fiducial Markers Market.
Contact
TechSci Research
LLC
420 Lexington
Avenue, Suite 300,
New York, United
States- 10170
Tel:
+1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com